4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function
- PMID: 11994439
- DOI: 10.4049/jimmunol.168.10.4897
4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function
Abstract
4-1BB (CD137) is a costimulatory member of the TNFR family expressed on activated T cells. Its ligand, 4-1BBL, is expressed on activated APC. In the mouse, CD8 T cells are preferentially activated by agonistic anti-murine 4-1BB Abs. However, murine 4-1BBL can stimulate both CD4 and CD8 T cells. To date, there are only limited data on the effects of 4-1BBL on human T cell responses. To further understand the role of 4-1BBL in human T cell responses, we compared human CD4 and CD8 T cell responses to transfected human 4-1BBL plus TCR-mediated stimulation. Both human CD4 and CD8 T cells responded to 4-1BBL. The presence of 4-1BBL on the APC led to increased expansion, cytokine production, and the development of cytolytic effector function by human T cells. In unfractionated T cell cultures, CD4 and CD8 T cells could expand to a similar extent in response to signals through the TCR and 4-1BB, as measured by CFSE labeling and by quantitating T cell numbers in the cultures. In contrast to the results with total T cells, isolated CD8 T cells produced less IL-2 and expanded to a lesser extent than isolated CD4 T cells responding to 4-1BBL. Thus, 4-1BBL is most effective when both CD4 and CD8 T cells are included in the cultures. CD28 and 4-1BB were found to synergize in the induction of IL-2 by human T cells, and CTLA-Ig partially blocked 4-1BBL-dependent IL-2 production. However, a portion of the 4-1BBL-mediated effects were independent of CD28-B7 interaction.
Similar articles
-
4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.J Immunol. 2001 Aug 1;167(3):1313-24. doi: 10.4049/jimmunol.167.3.1313. J Immunol. 2001. PMID: 11466348
-
Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection.J Immunol. 2002 Apr 15;168(8):3777-85. doi: 10.4049/jimmunol.168.8.3777. J Immunol. 2002. PMID: 11937529
-
4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.J Immunol. 2004 Nov 15;173(10):5944-51. doi: 10.4049/jimmunol.173.10.5944. J Immunol. 2004. PMID: 15528328
-
Anti-CD137 antibodies in the treatment of autoimmune disease and cancer.Immunol Res. 2004;29(1-3):197-208. doi: 10.1385/IR:29:1-3:197. Immunol Res. 2004. PMID: 15181282 Review.
-
Role of 4-1BB:4-1BB ligand in cancer immunotherapy.Cancer Gene Ther. 2004 Mar;11(3):215-26. doi: 10.1038/sj.cgt.7700670. Cancer Gene Ther. 2004. PMID: 14671675 Review.
Cited by
-
Harnessing NK Cell Checkpoint-Modulating Immunotherapies.Cancers (Basel). 2020 Jul 6;12(7):1807. doi: 10.3390/cancers12071807. Cancers (Basel). 2020. PMID: 32640575 Free PMC article. Review.
-
A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains.Nat Rev Clin Oncol. 2021 Nov;18(11):715-727. doi: 10.1038/s41571-021-00530-z. Epub 2021 Jul 6. Nat Rev Clin Oncol. 2021. PMID: 34230645 Review.
-
Identification of a p53 target, CD137L, that mediates growth suppression and immune response of osteosarcoma cells.Sci Rep. 2017 Sep 6;7(1):10739. doi: 10.1038/s41598-017-11208-x. Sci Rep. 2017. PMID: 28878391 Free PMC article.
-
Nicotine up-regulated 4-1BBL expression by activating Mek-PI3K pathway augments the efficacy of bone marrow-derived dendritic cell vaccination.J Clin Immunol. 2013 Jan;33(1):246-54. doi: 10.1007/s10875-012-9761-5. Epub 2012 Aug 17. J Clin Immunol. 2013. PMID: 22898831
-
Integrating costimulatory agonists to optimize immune-based cancer therapies.Immunotherapy. 2009 Mar;1(2):249-64. doi: 10.2217/1750743X.1.2.249. Immunotherapy. 2009. PMID: 20046961 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials